Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-03-17 06:04 am Purchase | 13G | Beam Therapeutics Inc. BEAM | Temasek Holdings (Private) Ltd | 3,644,573 5% | 766,276 (+26.62%) | View |
| 2023-02-14 08:27 am Sale | 13G | Beam Therapeutics Inc. BEAM | Farallon Capital Partners L.P. | 3,399,921 4.8% | -151,850 (-4.28%) | View |
| 2023-02-10 11:48 am Purchase | 13G | Beam Therapeutics Inc. BEAM | ARK Investment Management LLC | 8,213,131 11.65% | 229,730 (+2.88%) | View |
| 2023-02-10 06:10 am Sale | 13G | Beam Therapeutics Inc. BEAM | Temasek Holdings (Private) Ltd | 2,878,297 4.1% | -1,080,915 (-27.30%) | View |
| 2023-02-09 11:07 am Purchase | 13G | Beam Therapeutics Inc. BEAM | VANGUARD GROUP INC | 6,273,630 8.9% | 1,576,365 (+33.56%) | View |
| 2023-02-09 08:14 am Purchase | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 7,769,016 11.024% | 1,779,318 (+29.71%) | View |
| 2023-02-02 4:05 pm Purchase | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 5,238,280 7.4% | 1,175,486 (+28.93%) | View |
| 2022-07-14 3:55 pm Purchase | 13G | Beam Therapeutics Inc. BEAM | Farallon Capital Partners L.P. | 3,551,771 5.1% | 3,551,771 (New Position) | View |
| 2022-02-14 5:07 pm Sale | 13G | Beam Therapeutics Inc. BEAM | Redmile Group LLC | 1,885,850 2.8% | -1,892,412 (-50.09%) | View |
| 2022-02-14 4:04 pm Sale | 13G | Beam Therapeutics Inc. BEAM | HHLR ADVISORS LTD. | 0 0% | -2,966,403 (Position Closed) | View |
| 2022-02-14 12:04 pm Sale | 13G | Beam Therapeutics Inc. BEAM | ARCH Venture Fund IX L.P. | 5,871,150 8.6% | -2,371,889 (-28.77%) | View |
| 2022-02-14 06:38 am Purchase | 13G | Beam Therapeutics Inc. BEAM | Temasek Holdings (Private) Ltd | 3,959,212 5.8% | 604,571 (+18.02%) | View |
| 2022-02-09 3:24 pm Sale | 13G | Beam Therapeutics Inc. BEAM | VANGUARD GROUP INC | 4,697,265 6.89% | -5,970,702 (-55.97%) | View |
| 2022-02-09 2:05 pm Purchase | 13G | Beam Therapeutics Inc. BEAM | ARK Investment Management LLC | 7,983,401 11.72% | 1,676,852 (+26.59%) | View |
| 2022-02-09 09:09 am Sale | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 5,989,698 8.79% | -828,724 (-12.15%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 4,062,794 6% | 970,983 (+31.40%) | View |
| 2022-01-24 08:40 am Sale | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 6,818,422 10.007% | -510,164 (-6.96%) | View |
| 2021-06-10 1:14 pm Purchase | 13G | Beam Therapeutics Inc. BEAM | ARK Investment Management LLC | 6,306,549 10.08% | 6,306,549 (New Position) | View |
| 2021-04-09 6:02 pm Sale | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 3,091,811 5% | -67,699 (-2.14%) | View |
| 2021-02-16 4:18 pm Purchase | 13G | Beam Therapeutics Inc. BEAM | HHLR ADVISORS LTD. | 2,966,403 5.1% | 2,966,403 (New Position) | View |